FSD Liabilities And Stockholders Equity from 2010 to 2024

HUGE Stock  USD 0.32  0.01  3.03%   
FSD Pharma's Liabilities And Stockholders Equity is increasing over the years with slightly volatile fluctuation. Overall, Liabilities And Stockholders Equity is expected to go to about 25.4 M this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal FSD Pharma's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2016-06-30
Previous Quarter
18.9 M
Current Value
17.4 M
Quarterly Volatility
22.4 M
 
Covid
Check FSD Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among FSD main balance sheet or income statement drivers, such as Interest Expense of 289, Selling General Administrative of 10.1 M or Total Revenue of 0.0, as well as many exotic indicators such as Price To Sales Ratio of 278, Dividend Yield of 0.0 or PTB Ratio of 2.9. FSD financial statements analysis is a perfect complement when working with FSD Pharma Valuation or Volatility modules.
  
This module can also supplement FSD Pharma's financial leverage analysis and stock options assessment as well as various FSD Pharma Technical models . Check out the analysis of FSD Pharma Correlation against competitors.

Latest FSD Pharma's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of FSD Pharma Class over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. FSD Pharma's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in FSD Pharma's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

FSD Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean18,651,647
Geometric Mean0.00
Coefficient Of Variation115.40
Mean Deviation18,612,216
Median10,878,484
Standard Deviation21,523,602
Sample Variance463.3T
Range63M
R-Value0.73
Mean Square Error235.7T
R-Squared0.53
Significance0
Slope3,495,899
Total Sum of Squares6485.7T

FSD Liabilities And Stockholders Equity History

202425.4 M
202317.4 M
202238.4 M
202163 M
202042 M
201944 M
201838.7 M

About FSD Pharma Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include FSD Pharma income statement, its balance sheet, and the statement of cash flows. FSD Pharma investors use historical funamental indicators, such as FSD Pharma's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although FSD Pharma investors may use each financial statement separately, they are all related. The changes in FSD Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on FSD Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on FSD Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in FSD Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity17.4 M25.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether FSD Pharma Class is a strong investment it is important to analyze FSD Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact FSD Pharma's future performance. For an informed investment choice regarding FSD Stock, refer to the following important reports:
Check out the analysis of FSD Pharma Correlation against competitors.
Note that the FSD Pharma Class information on this page should be used as a complementary analysis to other FSD Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for FSD Stock analysis

When running FSD Pharma's price analysis, check to measure FSD Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FSD Pharma is operating at the current time. Most of FSD Pharma's value examination focuses on studying past and present price action to predict the probability of FSD Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FSD Pharma's price. Additionally, you may evaluate how the addition of FSD Pharma to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is FSD Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FSD Pharma. If investors know FSD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FSD Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.46)
Quarterly Revenue Growth
(0.07)
Return On Assets
(0.43)
Return On Equity
(0.84)
The market value of FSD Pharma Class is measured differently than its book value, which is the value of FSD that is recorded on the company's balance sheet. Investors also form their own opinion of FSD Pharma's value that differs from its market value or its book value, called intrinsic value, which is FSD Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FSD Pharma's market value can be influenced by many factors that don't directly affect FSD Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FSD Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if FSD Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FSD Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.